Joseph A Beavo

This inventor holds 17 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent, primarily in Phosphodiesterase Research. Top assignees: University of Washington, Icos Corporation, Vanderbilt University. Active years: 1995-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph A Beavo. Retrieved from https://idiyas.com/inventor/joseph-a-beavo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17

% Patents Active = 64.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1

Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 91(Granted Patents)

Company Filing History:

17 out of 2,173

University of Washington

Vanderbilt University

Icahn School of Medicine at Mount Sinai

patents

where one patent can have more than one assignee

Years Active: 1995-2010

Loading Chart...

Areas of Expertise:

Phosphodiesterases

DNA Encoding

Cyclic Nucleotide

cGMP

Screening Methods

Assay Methods

Calcium/Calmodulin

Antibodies

Mammalian

Modulation

Human Brain

Phosphodiesterase Activity

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7842478 - DNA encoding mammalian phosphodiesterases (2010-11-30),

2. 7598067 - PDEs and uses thereof (2009-10-06),

3. 7179614 - Screening methods to identify compounds that modulate type I phosphodiesterase (PDE) activity (2007-02-20),

4. 7138259 - PDEs and uses thereof (2006-11-21),

5. 7122363 - DNA encoding mammalian phosphodiesterases (2006-10-17),

6. 6642040 - Human cGMP-stimulated cyclic nucleotide phosphodiesterase (2003-11-04),

7. 6037119 - Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and (2000-03-14),

8. 6015677 - Assay methods using DNA encoding mammalian phosphodiesterases (2000-01-18),

9. 5955583 - Antibodies to cGMP-binding, cGMP-specific phospodiesterase (1999-09-21),

10. 5800987 - Assay methods using DNA encoding mammalian phosphodiesterases (1998-09-01),

11. 5789553 - Antibodies specifically immunoreactive with human brain Ca.sup.2+ (1998-08-04),

12. 5776752 - Isolated and purified calcium/calmodulin stimulated cyclic nucleotide (1998-07-07),

13. 5702936 - Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and (1997-12-30),

14. 5652131 - Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and (1997-07-29),

15. 5602019 - DNA encoding mammalian phosphodiesterases (1997-02-11),

Title: Joseph A Beavo: Innovator in Phosphodiesterase Research

Introduction

Joseph A Beavo is a prominent inventor based in Seattle, WA (US). He has made significant contributions to the field of biochemistry, particularly in the study of phosphodiesterases. With a total of 17 patents, his work has advanced our understanding of these important enzymes.

Latest Patents

Among his latest patents, Beavo has developed novel purified and isolated nucleotide sequences encoding mammalian Ca/calmodulin stimulated phosphodiesterases (CaM-PDEs) and cyclic-GMP-stimulated phosphodiesterases (cGS-PDEs). This invention includes the corresponding recombinant expression products, immunological reagents, and methods for identifying compounds that modulate the enzymatic activity of these expression products. Another significant patent provides isolated full-length nucleic acid molecules encoding a novel PDE protein, along with methods for their use. This includes peptide nucleic acids (PNA) and antisense molecules that interact with the nucleic acid molecules, as well as agonists, antibodies, antagonists, or inhibitors of the activity of these novel PDE proteins. These compositions are valuable for diagnosing, preventing, or treating conditions related to the presence or deficiency of these proteins.

Career Highlights

Joseph A Beavo has had a distinguished career, working with notable institutions such as the University of Washington and Icos Corporation. His research has been pivotal in the development of therapeutic strategies targeting phosphodiesterases.

Collaborations

Throughout his career, Beavo has collaborated with esteemed colleagues, including William K Sonnenburg and Harry Charbonneau. Their combined expertise has contributed to the advancement of research in this field.

Conclusion

Joseph A Beavo's innovative work in phosphodiesterase research has led to numerous patents and significant advancements in biochemistry. His contributions continue to impact the scientific community and pave the way for future discoveries.

Profile summary based on public USPTO records.